Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2021

Apr 15, 2021

32106_dirs_2021-04-14_bc999460-55da-4b54-b6b8-a19d9e40bae8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-04-12

Reporting Person: DE GREEF RODERICK (CFO & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-12 Common Stock A 3222 Acquired 185538 Direct

Footnotes

F1: The restricted stock award was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests in six (6) months.